A New Force-Activated Separation Device for the Prevention of Peripheral Intravenous Restarts

Area of Science:

• Medical Devices
• Patient Safety
• Clinical Trials

Background:

• Peripheral intravenous catheters (PIVCs) exhibit a high failure rate of 46%.
• Limited research exists on the impact of external forces on PIVC complications.
• Force-activated separation devices (FASD) are designed to detach under damaging forces, preventing catheter damage.

Purpose of the Study:

• To evaluate the efficacy of FASD in reducing mechanical complications associated with PIVCs.
• To compare the incidence of PIVC restarts, therapy delays, and adverse events between standard care and FASD-augmented care.

Main Methods:

• A randomized controlled trial involving 302 patients assigned to either standard of care (SOC) or SOC with FASD.
• Primary outcome: total mechanical complications requiring PIVC restart.
• Secondary outcomes: delay in therapy, PIVC restarts, and adverse events. Intention-to-treat and per-protocol analyses were conducted.

Main Results:

• FASD group showed significantly fewer total mechanical complications (22) compared to SOC (41; P < .01).
• The SOC group experienced a greater estimated total delay in therapy (B = 69.53 minutes; P = .001).
• Adverse events were substantially lower in the FASD group (76) versus SOC (127; P = .001).

Conclusions:

• The use of FASD demonstrated a significant reduction in total mechanical complications.
• FASD represents a safer and more time-efficient alternative to current standard PIVC care.
• Study findings support the integration of FASD into routine clinical practice for improved patient outcomes.